1,25-Dihydroxyvitamin D₃– a hormone with immunomodulatory properties

Summary

The active vitamin D metabolite, 1,25-dihydroxyvitamin D₃ [1,25-(OH)₂D₃], exerts immunosuppressive activity. At a cellular and molecular level, the hormone preferentially targets helper T cell activity (Th1) by inhibiting the secretion of both IL-2 and IFN-γ by Th1 and by suppressing the secretion pro-Th1 cytokine IL-12 by antigen-presenting cells. The active metabolite further inhibits class II antigen expression and enhances suppressor cell activity.

In animal models of autoimmunity, 1,25-(OH)₂D₃ prevents the development of experimental autoimmune encephalomyelitis, reduces the incidence of diabetes, and attenuates murine lupus. The hormone also prolongs graft survival in animal models of transplantation.

In humans, non-classical use of 1,25-(OH)₂D₃ has led to an anti-proliferative effect in psoriasis, anti-neoplastic effect in prostate cancer, and immunomodulatory effect in scleroderma. The development of less hypercalcemic analogs might open a new therapeutic area for vitamin D₃.